Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Eperisone

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 68Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 64840-90-0, 1-(4-ethylphenyl)-2-methyl-3-(piperidin-1-yl)propan-1-one, Eperisone [inn], 4'-ethyl-2-methyl-3-piperidinopropiophenone, 1-(4-ethylphenyl)-2-methyl-3-piperidin-1-ylpropan-1-one, 1-(4-ethylphenyl)-2-methyl-3-(1-piperidinyl)-1-propanone
    Molecular Formula
    C17H25NO
    Molecular Weight
    259.4  g/mol
    InChI Key
    SQUNAWUMZGQQJD-UHFFFAOYSA-N
    FDA UNII
    2M2P0551D3
    Eperisone is an antispasmodic drug which relaxes both skeletal muscles and vascular smooth muscles, and demonstrates a variety of effects such as reduction of myotonia, improvement of circulation, and suppression of the pain reflex. It is not approved for use in the United States, but is available in other countries like India, South Korea, and Bangladesh.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    1-(4-ethylphenyl)-2-methyl-3-piperidin-1-ylpropan-1-one
    2.1.2 InChI
    InChI=1S/C17H25NO/c1-3-15-7-9-16(10-8-15)17(19)14(2)13-18-11-5-4-6-12-18/h7-10,14H,3-6,11-13H2,1-2H3
    2.1.3 InChI Key
    SQUNAWUMZGQQJD-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CCC1=CC=C(C=C1)C(=O)C(C)CN2CCCCC2
    2.2 Other Identifiers
    2.2.1 UNII
    2M2P0551D3
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. (4'-ethyl-2-methyl-3-piperidino)propiophenone

    2. 4-empp

    3. E-0646

    2.3.2 Depositor-Supplied Synonyms

    1. 64840-90-0

    2. 1-(4-ethylphenyl)-2-methyl-3-(piperidin-1-yl)propan-1-one

    3. Eperisone [inn]

    4. 4'-ethyl-2-methyl-3-piperidinopropiophenone

    5. 1-(4-ethylphenyl)-2-methyl-3-piperidin-1-ylpropan-1-one

    6. 1-(4-ethylphenyl)-2-methyl-3-(1-piperidinyl)-1-propanone

    7. Chebi:77070

    8. Eperisone (inn)

    9. 2m2p0551d3

    10. (+-)-eperisone

    11. Eperisonum

    12. Eperisona

    13. Eperisonum [inn-latin]

    14. Eperisona [inn-spanish]

    15. Ncgc00167973-01

    16. Brn 1246496

    17. Unii-2m2p0551d3

    18. Eperisone [jan]

    19. Eperisone [mi]

    20. Eperisone [who-dd]

    21. Schembl194769

    22. Chembl1902981

    23. Dtxsid5040671

    24. 1-propanone, 1-(4-ethylphenyl)-2-methyl-3-(1-piperidinyl)-

    25. Akos015960753

    26. Db08992

    27. Ac-12144

    28. Db-054734

    29. Hy-128891

    30. Cs-0101898

    31. Ft-0630750

    32. D07898

    33. 840e900

    34. Q426401

    35. Brd-a04252265-001-01-8

    36. (2rs)-1-(4-ethylphenyl)-2-methyl-3-(1-piperidyl)propan-1-one

    2.4 Create Date
    2005-03-25
    3 Chemical and Physical Properties
    Molecular Weight 259.4 g/mol
    Molecular Formula C17H25NO
    XLogP33.8
    Hydrogen Bond Donor Count0
    Hydrogen Bond Acceptor Count2
    Rotatable Bond Count5
    Exact Mass259.193614421 g/mol
    Monoisotopic Mass259.193614421 g/mol
    Topological Polar Surface Area20.3 Ų
    Heavy Atom Count19
    Formal Charge0
    Complexity275
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count1
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Anticonvulsants

    Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)

    Vasodilator Agents

    Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)

    Parasympatholytics

    Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)

    Muscle Relaxants, Central

    A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) (See all compounds classified as Muscle Relaxants, Central.)

    Calcium Channel Blockers

    A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)

    4.2 ATC Code

    M - Musculo-skeletal system

    M03 - Muscle relaxants

    M03B - Muscle relaxants, centrally acting agents

    M03BX - Other centrally acting agents

    M03BX09 - Eperisone